Alerts will be sent to your verified email
Verify Email
None
|
Speciality Medicines
|
Remus Pharmaceutical
|
Trident Lifeline
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
38.23 % | 22.94 % | 31.52 % |
|
5yr average Equity Multiplier
|
2.01 | 1.87 | 2.03 |
|
5yr Average Asset Turnover Ratio
|
2.86 | 1.12 | 0.82 |
|
5yr Avg Net Profit Margin
|
9.1 % | 11.07 % | 16.21 % |
|
Price to Book
|
n/a | 2.74 | 3.62 |
|
P/E
|
n/a | 24.16 | 24.92 |
|
5yr Avg Cash Conversion Cycle
|
128.49 Days | 37.04 Days | 61.09 Days |
|
Inventory Days
|
60.0 Days | 36.45 Days | 72.84 Days |
|
Days Receivable
|
63.56 Days | 65.7 Days | 86.3 Days |
|
Days Payable
|
27.57 Days | 111.91 Days | 122.66 Days |
|
5yr Average Interest Coverage Ratio
|
26.44 | 48.28 | 14.53 |
|
5yr Avg ROCE
|
54.65 % | 25.27 % | 26.3 % |
|
5yr Avg Operating Profit Margin
|
13.99 % | 14.8 % | 16.98 % |
|
5 yr average Debt to Equity
|
0.4 | 0.19 | 0.47 |
|
5yr CAGR Net Profit
|
42.22 % | 27.88 % | 24.36 % |
|
5yr Average Return on Assets
|
18.23 % | 12.5 % | 13.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
n/a | 70.91 % | 64.11 % |
|
Share Pledged by Promoters
|
n/a | 0.0 | 6.77 % |
|
Change in Promoter Holding (3 Yrs)
|
n/a | 1.3 % | -5.74 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 | 0.0 |
|
Speciality Medicines
|
Remus Pharmaceutical
|
Trident Lifeline
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|